Original ArticlesA Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic TractPors, Jennifer MD*; Cheng, Angela BSc†; Leo, Joyce M. MD‡; Kinloch, Mary A. MD§; Gilks, Blake MD*,†; Hoang, Lynn MD*,†Author Information *Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia †Genetic Pathology Evaluation Center, Vancouver ‡Department of Pathology, Royal Jubilee Hospital, Victoria, BC §Department of Pathology, Saskatoon City Hospital, Saskatoon, SK, Canada This study has been presented as an abstract at the 2017 European Congress of Pathology (ECP) meeting. Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article. Correspondence: Lynn Hoang, MD, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver General Hospital, 1215—910 West 10th Avenue, Vancouver, BC, Canada V5Z 1M9 (e-mail: [email protected]). The American Journal of Surgical Pathology: December 2018 - Volume 42 - Issue 12 - p 1596-1606 doi: 10.1097/PAS.0000000000001142 Buy Metrics Abstract Mesonephric carcinomas of the gynecologic tract are neoplasms that are often under-recognized due to their varied morphologic appearances. Recently, GATA3 and TTF1 have been reported to be useful immunohistochemical markers for distinguishing mesonephric carcinomas from its morphologic mimics. Herein, we compared the performance of GATA3 and TTF1 to the traditional markers used for mesonephric carcinomas, CD10 and calretinin. We studied 694 cases: 8 mesonephric carcinomas (7 cervical [includes 3 mesonephric carcinosarcomas], 1 vaginal), 5 mesonephric-like carcinomas (4 uterine corpus, 1 ovarian), 585 endometrial adenocarcinomas, and 96 cervical adenocarcinomas. Mesonephric-like carcinomas were defined as tumors exhibiting the classic morphologic features of mesonephric carcinoma, but occurring outside of the cervix and without convincing mesonephric remnants. GATA3 had the highest sensitivity and specificity (91% and 94%) compared with TTF1 (45% and 99%), CD10 (73% and 83%), and calretinin (36% and 89%). GATA3, however, also stained a substantial number of uterine carcinosarcomas (23/113, 20%). TTF1 was positive in 5/5 (100%) mesonephric-like carcinomas and only 1/8 (13%) mesonephric carcinomas. In 4/6 (67%) TTF1 positive cases, GATA3 exhibited an inverse staining pattern with TTF1. In summary, GATA3 was the best overall marker for mesonephric and mesonephric-like carcinomas, but cannot be used to distinguish mesonephric carcinosarcomas from Müllerian carcinosarcomas. The inverse staining pattern between GATA3 and TTF1, suggests that TTF1 may be useful when GATA3 is negative in small biopsies where mesonephric or mesonephric-like carcinoma is suspected. The greater TTF1 positivity in mesonephric-like carcinomas suggests they may be biologically different from prototypical mesonephric carcinomas. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.